In breast cancer, estrogen induces FOSL2/Wnt5a expression via cAMP/PKA signaling, in turn, the secreted Wnt5a regulates FZD5/NK-kB/ERK signaling in vascular endothelial cells to promote tumor angiogenesis [234]. The gene discussed is WNT5A; the disease is breast carcinoma.